← Back to Search

SurgeCon Platform for Emergency Department Efficiency (SurgeCon Trial)

N/A

Recruiting

Led By Shabnam Shabnam, PhD

Research Sponsored by Memorial University of Newfoundland

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 31 months

Awards & highlights

SurgeCon Trial Summary

This trial studied how to reduce emergency department wait times with a software platform called SurgeCon. They found that it reduced wait times by 32%.

Who is the study for?

This trial is for anyone visiting one of the four selected emergency departments during the study period. There are no specific exclusion criteria, meaning it's open to all individuals who come in for care.Check my eligibility

What is being tested?

SurgeCon, a new software platform and set of initiatives designed to reduce wait times in emergency departments, is being tested. The goal is to improve efficiency without needing more staff.See study design

What are the potential side effects?

Since SurgeCon is a management tool rather than a medical treatment, there aren't any direct side effects like you'd expect with medication or surgery.

SurgeCon Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 31 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~31 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 31 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Length of stay

Number of patients left without being seen

Time to physician's initial assessment

Secondary outcome measures

Economic impact of intervention on emergency department services

Patient satisfaction and patient reported experiences with ED wait time

SurgeCon Trial Design

4Treatment groups

Experimental Treatment

Group I: Hospital site 4Experimental Treatment1 Intervention

This site will provide usual ED care during the control period which will last for the first 24 months of the study. After 24 months this site will begin transitioning to the SurgeCon management platform which they will use until the end of the study.

Group II: Hospital site 3Experimental Treatment1 Intervention

This site will provide usual ED care during the control period which will last for the first 18 months of the study. After 18 months this site will begin transitioning to the SurgeCon management platform which they will use until the end of the study.

Group III: Hospital site 2Experimental Treatment1 Intervention

This site will provide usual ED care during the control period which will last for the first 12 months of the study. After 12 months this site will begin transitioning to the SurgeCon management platform which they will use until the end of the study.

Group IV: Hospital site 1Experimental Treatment1 Intervention

This site will provide usual ED care during the control period which will last for the first six months of the study. After six months this site will begin transitioning to the SurgeCon management platform which they will use until the end of the study.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Memorial University of NewfoundlandLead Sponsor

68 Previous Clinical Trials

1,811,742 Total Patients Enrolled

Canadian Institutes of Health Research (CIHR)OTHER_GOV

1,344 Previous Clinical Trials

26,433,137 Total Patients Enrolled

Government of Newfoundland and LabradorOTHER_GOV

1 Previous Clinical Trials

76 Total Patients Enrolled

Media Library

SurgeCon Clinical Trial Eligibility Overview. Trial Name: NCT04789902 — N/A

Length of Stay Research Study Groups: Hospital site 4, Hospital site 1, Hospital site 2, Hospital site 3

Length of Stay Clinical Trial 2023: SurgeCon Highlights & Side Effects. Trial Name: NCT04789902 — N/A

SurgeCon 2023 Treatment Timeline for Medical Study. Trial Name: NCT04789902 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experiment recruiting new participants at this time?

"Affirmative. The clinicaltrials.gov website discloses that this research endeavour is currently recruiting participants, having been posted on January 1st 2021 and last updated September 6th 2022. It aspires to enrol 20280 people from 4 sites in total."

Answered by AI

What is the sample size of this clinical investigation?

"Affirmative. Clinicaltrials.gov attests that this investigation, which was initially advertised on January 1st 2021, is currently seeking participants. The research requires 20280 individuals to be recruited from 4 distinct clinical centres."

Answered by AI

Recent research and studies

Journal of Trauma: Injury, Infection & Critical CareJournal

Commitment to COT Verification Improves Patient Outcomes and Financial Performance

Maggio, Paul M., Susan I. Brundage, Tina Hernandez-Boussard, and David A. Spain. 2009. “Commitment to COT Verification Improves Patient Outcomes and Financial Performance”. Journal of Trauma: Injury, Infection & Critical Care. Ovid Technologies (Wolters Kluwer Health). doi:10.1097/ta.0b013e3181a51b2f.

Clinical and Experimental Emergency MedicineJournal

Improving Emergency Department Patient Flow

Jarvis, Paul Richard Edwin. 2016. “Improving Emergency Department Patient Flow”. Clinical and Experimental Emergency Medicine. The Korean Society of Emergency Medicine. doi:10.15441/ceem.16.127.

Academic Emergency MedicineJournal

Effects of Emergency Department Expansion on Emergency Department Patient Flow

Mumma, Bryn E., James Y. McCue, Chin-Shang Li, and James F. Holmes. 2014. “Effects of Emergency Department Expansion on Emergency Department Patient Flow”. Edited by Jesse Pines. Academic Emergency Medicine. Wiley. doi:10.1111/acem.12366.

Military MedicineJournal